Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Rapid Reactions

Enabling KarXT
CME: Enabling Real-World Use of KarXT: Evidence for Practical and Flexible Switching Strategies
CHRISTOPH U. CORRELL, MD

Clinical Professor, Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NY, USA
Professor of Psychiatric Neuroscience, Institute of Behavioral Science, Feinstein Institutes for Medical Research, NY, USA
Professor and Chair, Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charite University Medicine-Berlin, Berlin, Germany
Guiding Antipsychotic
CME: Guiding Antipsychotic Selection: What Large-Scale Comparative Evidence Tells Us
Solaris
CME: Phase 3 SOLARIS: Efficacy, Safety, and Quality-of-Life Outcomes with TV-44749
Titration to Tolerability
CME: From Titration to Tolerability: Practical Dosing Insights for KarXT
LB-102
CME: A New Approach to Cognitive Impairment in Schizophrenia: Insights from LB-102 Phase 2
Enabling KarXT
CME: Enabling Real-World Use of KarXT: Evidence for Practical and Flexible Switching Strategies
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy